424B5 filed Nov 10, 2026 at 17:01 ET
Neuronetics filed a 424B5 prospectus supplement for an underwritten public offering of common stock, with share count, price, and net proceeds left as placeholders (TBD). Proceeds will partially repay the $65M Perceptive credit facility (11.5% interest) and fund general corporate purposes. The offering follows a Q3 2026 earnings beat (revenue $42.0M, +12.5% YoY; EPS -$0.02 vs -$0.11 consensus) and a November 5, 2026 amendment to the Perceptive Facility that requires a $15M prepayment by November 30, 2026 to avoid automatic termination. The company has a going concern warning tied to trailing twelve-month revenue projections.